NIAID Funding News, April 6, 2022

April 6, 2022 NIAID Funding News Read this full edition online at https://www.niaid.nih.gov/grants-contracts/funding-news/2022-04-06 Feature Articles  NIH and Tribal Nations—Commitment and Collaboration Regular, meaningful engagement with Tribal partners helps NIH ensure American Indians and Alaska Natives are well-represented in biomedical research and benefit from its outcomes. Opportunities and Resources Research Early-Stage HIV Broadly Neutralizing Antibody Susceptibility Assays NIAID encourages studies that facilitate early-stage assay development and demonstrate feasibility and clinical utility, followed by verification and late-stage method validation. RAPPS Contracts—Resources To Advance Pediatrics and HIV Prevention Science NIAID seeks contractors to support preclinical HIV research, develop pediatric formulations, and advance next-generation HIV prevention and treatment products. Submit Applications To Improve Drug Susceptibility Testing for Tuberculosis Help improve treatment decisions for patients by honing drug susceptibility testing methods and thus reduce rates of drug-resistant tuberculosis in the community. NIAID Funding Available for Biocontainment Facility Improvements NIAID will sponsor facility improvements and building systems upgrades at existing biosafety level 3 and biosafety level 4 laboratories engaged in research on RNA viruses of pandemic potential. In The News A Special Thank You to AViDD Peer Reviewers Reviewers committed unusually high levels of effort in a short time to help NIAID identify and fund key research on innovative antiviral drug development targeting coronaviruses and other select RNA viruses. Send Feedback To Inform NIAID's Approach to Sex Differences in Radiation Research We hope to gain insight into the current research landscape on sex differences in radiation injury and specifically learn about challenges and gaps in the field. Attend Webinar on Peer Review of Small Business Research Applications Join us for a webinar on April 19, 2022, to discuss the review process for small business innovation research and small business technology transfer grant applications. Nominate an Early-Stage Investigator for SGM Research Award Program Nominees should be early-stage investigators who have made substantial, outstanding research contributions in areas related to sexual and gender minority health and are poised to become future leaders in the field. Advice Corner G11 Sample Applications and Opportunity for Foreign Grant Administrators Three new high-scoring, successful G11 samples reflect excellent grantsmanship and serve as educational resources for other applicants and award administrators. Reader Questions "What does the term 'successor-in-interest' mean?" "Is there a webpage that lists all of NIAID's standard operating procedures for grants?" New Funding Opportunities RFA-AI-22-020, Development and Optimization of Next-Generation Immunological Assays to Support Influenza Clinical Studies and Trials (UH2/UH3, Clinical Trial Not Allowed) RFA-AI-22-025, Enhancing HIV Reservoir Susceptibility to Elimination (R01, Clinical Trial Not Allowed) RFA-AI-22-028, Partnerships for the Development of Novel Therapeutics To Combat Select Antibiotic Resistant Bacteria and Fungi (R01, Clinical Trial Not Allowed) RFA-OD-22-009, Transformative Research Award for the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndrome) Project (R01, Clinical Trial Not Allowed) NOT-GM-22-005, Notice of Special Interest (NOSI)—Administrative Supplements for Research on Womens Health in the IDeA States Find other announcements at NIAID Opportunities & Announcements. Send suggestions or comments to deaweb@niaid.nih.gov. National Institute of Allergy and Infectious Diseases  |  National Institutes of Health Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact Subscriber Help. This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID).                             This email was sent to rssproject471@gmail.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107

Tweet

Postingan terkait:

— Wednesday, April 6, 2022 — Add Comment